LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.94 | 17.25 | 11338 | 5681 | 1.9955 | 1.1722 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.94 | 17.25 | 4 | 5681 | 0.0007 | -0.1603 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.94 | 17.25 | 10976 | 5681 | 1.9318 | 1.1638 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.91 | 17.25 | 2 | 5730 | 0.0003 | -0.2268 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.91 | 17.25 | 11570 | 5730 | 2.0190 | 1.1750 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.91 | 17.25 | 3 | 5730 | 0.0005 | -0.1885 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.91 | 17.25 | 11214 | 5730 | 1.9569 | 1.1669 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.88 | 17.25 | 2 | 5826 | 0.0003 | -0.2263 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.88 | 17.25 | 11841 | 5826 | 2.0324 | 1.1762 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.88 | 17.25 | 2 | 5826 | 0.0003 | -0.2263 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.88 | 17.25 | 11478 | 5826 | 1.9701 | 1.1682 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.85 | 17.25 | 2 | 5861 | 0.0003 | -0.2261 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.85 | 17.25 | 12122 | 5861 | 2.0680 | 1.1805 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.85 | 17.25 | 1 | 5861 | 0.0002 | -0.2873 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.85 | 17.25 | 11417 | 5861 | 1.9477 | 1.1650 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.82 | 17.25 | 1 | 5924 | 0.0002 | -0.2869 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.82 | 17.25 | 12239 | 5924 | 2.0660 | 1.1799 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.82 | 17.25 | 2 | 5924 | 0.0003 | -0.2257 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 84.82 | 17.25 | 11634 | 5924 | 1.9638 | 1.1668 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.79 | 17.25 | 12473 | 6008 | 2.0760 | 1.1807 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 86.79 | 17.25 | 11667 | 6008 | 1.9418 | 1.1635 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.76 | 17.25 | 1 | 6047 | 0.0002 | -0.2860 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.76 | 17.25 | 12560 | 6047 | 2.0767 | 1.1806 | MN20160310_N02 | L17 |